ABBOTT LABORATORIES
For the period ended Dec 31, 2023. Filed Feb 16, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 16, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, Abbott Laboratories has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ABBOTT LABORATORIES | |
| By | /s/ ROBERT B. FORD |
| Robert B. Ford | |
| Chairman of the Board and Chief Executive Officer | |
| Date: | February 16, 2024 |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of Abbott Laboratories on February 16, 2024 in the capacities indicated below.
| /s/ ROBERT B. FORD | /s/ PHILIP P. BOUDREAU |
|---|---|
| Robert B. Ford | Philip P. Boudreau |
| Chairman of the Board and Chief Executive Officer, and Director of Abbott Laboratories (principal executive officer) | Senior Vice President, Finance and Chief Financial Officer (principal financial officer) |
| /s/ JOHN A. MCCOY, JR. | |
| John A. McCoy, Jr. | |
| Vice President, Finance and Controller(principal accounting officer) | |
| /s/ ROBERT J. ALPERN | /s/ CLAIRE BABINEAUX-FONTENOT |
| Robert J. Alpern, M.D. | Claire Babineaux-Fontenot |
| Director of Abbott Laboratories | Director of Abbott Laboratories |
| /s/ SALLY E. BLOUNT | /s/ PAOLA GONZALEZ |
| Sally E. Blount, Ph.D. | Paola Gonzalez |
| Director of Abbott Laboratories | Director of Abbott Laboratories |
| /s/ MICHELLE A. KUMBIER | /s/ DARREN W. MCDEW |
| Michelle A. Kumbier | Darren W. McDew |
| Director of Abbott Laboratories | Director of Abbott Laboratories |
| /s/ NANCY MCKINSTRY | /s/ MICHAEL G. O'GRADY |
| Nancy McKinstry | Michael G. O'Grady |
| Director of Abbott Laboratories | Director of Abbott Laboratories |
| /s/ MICHAEL F. ROMAN | /s/ DANIEL J. STARKS |
| Michael F. Roman | Daniel J. Starks |
| Director of Abbott Laboratories | Director of Abbott Laboratories |
| /s/ JOHN G. STRATTON | |
| John G. Stratton | |
| Director of Abbott Laboratories | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.